Beijing Safe Pharmaceutical Technology Co., Ltd.
PrivateLast Round
IPO
Feb 26, 2021
Est. Valuation
$6.5B
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Beijing Safe Pharmaceutical Technology Co., Ltd. is a biotechnology company that provides preclinical safety assessment, toxicology services, and drug development support for biopharmaceutical and medical device companies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Safe Pharmaceutical Technology Co., Ltd. Comparables
Compare Beijing Safe Pharmaceutical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Joinn Laboratories (China) Co., Ltd. | 91% | |
| Shanghai InnoStar Bio-tech Co., Ltd. | 88% | |
| Frontage Holdings Corporation | 86% |
Beijing Safe Pharmaceutical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Feb 26, 2021 | ||||
| IPO | Aug 25, 2017 |
Beijing Safe Pharmaceutical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CLSA | IPO |
| Lake Bleu Capital | IPO |
| 招银国际金融有限公司 | IPO |
| The Valliance Fund | IPO |
| China International Capital Corporation | IPO |
| OrbiMed | IPO |
| Sequoia Capital | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 133, 1209% of headcount.
- Feb 26, 2021
$806M IPO round led by CLSA.
Beijing Safe Pharmaceutical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessAppears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Beijing Safe Pharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Safe Pharmaceutical Technology Co., Ltd. a public or private company?
Beijing Safe Pharmaceutical Technology Co., Ltd. is a private company.
What is the current stock price of Beijing Safe Pharmaceutical Technology Co., Ltd.?
Beijing Safe Pharmaceutical Technology Co., Ltd. is a private company with no public stock price. Caplight tracks Beijing Safe Pharmaceutical Technology Co., Ltd.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Beijing Safe Pharmaceutical Technology Co., Ltd. worth (valuation)?
Beijing Safe Pharmaceutical Technology Co., Ltd.'s valuation is estimated at $6.5B based on funding round data.
Can I buy Beijing Safe Pharmaceutical Technology Co., Ltd. stock?
Beijing Safe Pharmaceutical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Safe Pharmaceutical Technology Co., Ltd.'s last funding round?
Beijing Safe Pharmaceutical Technology Co., Ltd.'s most recent funding round was IPO on February 26, 2021.
Who are the main investors in Beijing Safe Pharmaceutical Technology Co., Ltd.?
Key investors in Beijing Safe Pharmaceutical Technology Co., Ltd. include CLSA.
Will Beijing Safe Pharmaceutical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Safe Pharmaceutical Technology Co., Ltd..
How can I track Beijing Safe Pharmaceutical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Safe Pharmaceutical Technology Co., Ltd.'s secondary market activity and sign up for updates.